$INVA
Innoviva, Inc. Stock $inva

$inva Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000110465912072730 Filed on October 31, 2012

Income Statement

Concept	2012 Q4	2012 Q3	2011 Q4
Revenue	$5.800M	$1.430M	$5.400M
YoY Change	7.41%	-77.76%	-21.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$7.700M	$7.754M	$8.500M
YoY Change	-9.41%	-0.59%	14.86%
% of Gross Profit
Research & Development	$28.10M	$27.03M	$32.50M
YoY Change	-13.54%	-2.91%	85.71%
% of Gross Profit
Depreciation & Amortization	-$2.200M	$1.900M	$2.100M
YoY Change	-204.76%	-9.52%	31.25%
% of Gross Profit
Operating Expenses	$35.80M	$34.78M	$40.90M
YoY Change	-12.47%	-2.39%	64.26%
Operating Profit		-$33.35M
YoY Change
Interest Expense	-$1.300M	$1.500M	-$1.400M
YoY Change	-7.14%	-0.33%	0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$31.30M	-$34.70M	-$37.00M
YoY Change	-15.41%	13.4%	91.71%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$31.30M	-$34.70M	-$37.00M
YoY Change	-15.41%	13.4%	91.71%
Net Earnings / Revenue	-539.66%	-2426.57%	-685.19%
Basic Earnings Per Share		-$0.37
Diluted Earnings Per Share	-$326.7K	-$0.37	-$446.3K
COMMON SHARES
Basic Shares Outstanding	97.86M shares	95.03M shares	85.13M shares
Diluted Shares Outstanding		95.03M shares

Balance Sheet

Concept	2012 Q4	2012 Q3	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$248.5M	$273.4M	$240.9M
YoY Change	3.14%	3.11%	-22.19%
Cash & Equivalents	$94.85M	$112.2M	$44.78M
Short-Term Investments	$153.6M	$161.2M	$196.1M
Other Short-Term Assets	$4.000M	$3.800M	$3.500M
YoY Change	14.29%	0.0%	-41.67%
Inventory	$7.514M	$5.100M	$0.00
Prepaid Expenses
Receivables	$0.00	$100.0K	$200.0K
Other Receivables	$100.0K	$100.0K	$100.0K
Total Short-Term Assets	$261.1M	$282.5M	$244.8M
YoY Change	6.69%	4.97%	-22.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.154M	$9.579M	$10.37M
YoY Change	-11.74%	-6.09%	1.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$95.20M	$89.00M	$0.00
YoY Change
Other Assets	$2.268M	$1.894M	$2.514M
YoY Change	-9.79%	-47.39%	-24.73%
Total Long-Term Assets	$107.4M	$101.4M	$14.02M
YoY Change	666.45%	616.16%	-5.58%
TOTAL ASSETS
Total Short-Term Assets	$261.1M	$282.5M	$244.8M
Total Long-Term Assets	$107.4M	$101.4M	$14.02M
Total Assets	$368.6M	$383.9M	$258.8M
YoY Change	42.43%	35.51%	-21.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.377M	$4.757M	$5.813M
YoY Change	-7.5%	28.57%	173.17%
Accrued Expenses	$20.00M	$17.40M	$20.90M
YoY Change	-4.31%	15.23%	32.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$29.97M	$27.09M	$45.50M
YoY Change	-34.13%	-31.96%	13.59%
LONG-TERM LIABILITIES
Long-Term Debt	$172.5M	$172.5M	$172.5M
YoY Change	0.0%	0.0%	-0.06%
Other Long-Term Liabilities	$11.10M	$11.10M	$127.8M
YoY Change	-91.31%	-91.47%	-9.36%
Total Long-Term Liabilities	$183.6M	$183.6M	$300.3M
YoY Change	-38.86%	-39.35%	-4.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.97M	$27.09M	$45.50M
Total Long-Term Liabilities	$183.6M	$183.6M	$300.3M
Total Liabilities	$213.6M	$210.7M	$345.8M
YoY Change	-38.23%	-38.48%	-2.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.335B	-$1.303B	-$1.316B
YoY Change	1.41%		9.61%
Common Stock	$1.489B	$1.476B	$1.229B
YoY Change	21.2%		4.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$155.0M	$173.3M	-$87.05M
YoY Change
Total Liabilities & Shareholders Equity	$368.6M	$383.9M	$258.8M
YoY Change	42.43%	35.51%	-21.87%

Cashflow Statement

Concept	2012 Q4	2012 Q3	2011 Q4
OPERATING ACTIVITIES
Net Income	-$31.30M	-$34.70M	-$37.00M
YoY Change	-15.41%	13.4%	91.71%
Depreciation, Depletion And Amortization	-$2.200M	$1.900M	$2.100M
YoY Change	-204.76%	-9.52%	31.25%
Cash From Operating Activities	-$24.20M	-$27.60M	-$25.30M
YoY Change	-4.35%	43.01%	68.67%
INVESTING ACTIVITIES
Capital Expenditures	-$300.0K	-$500.0K	-$900.0K
YoY Change	-66.67%	-600.0%	50.0%
Acquisitions
YoY Change
Other Investing Activities	$400.0K	-$33.10M	$5.400M
YoY Change	-92.59%	234.34%	-130.86%
Cash From Investing Activities	$100.0K	-$33.70M	$4.600M
YoY Change	-97.83%	240.4%	-125.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.800M	12.40M	2.800M
YoY Change	142.86%	785.71%	-97.9%
NET CHANGE
Cash From Operating Activities	-24.20M	-27.60M	-25.30M
Cash From Investing Activities	100.0K	-33.70M	4.600M
Cash From Financing Activities	6.800M	12.40M	2.800M
Net Change In Cash	-17.30M	-48.90M	-17.90M
YoY Change	-3.35%	75.9%	-117.85%
FREE CASH FLOW
Cash From Operating Activities	-$24.20M	-$27.60M	-$25.30M
Capital Expenditures	-$300.0K	-$500.0K	-$900.0K
Free Cash Flow	-$23.90M	-$27.10M	-$24.40M
YoY Change	-2.05%	39.69%	69.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.96
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2012Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	97857208	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62736000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	196137000	USD
CY2011Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	223000	USD
CY2011Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	100000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3525000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	244763000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	893000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10372000	USD
CY2011Q4	us-gaap	Due From Employees Noncurrent DueFromEmployeesNoncurrent	240000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2514000	USD
CY2011Q4	us-gaap	Assets Assets	258782000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5813000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	5821000	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	122017000	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9643000	USD
CY2011Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6956000	USD
CY2011Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2372000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1946000	USD
CY2011Q4	us-gaap	Debt Current DebtCurrent	69000	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	18697000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45496000	USD
CY2011Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	172500000	USD
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.96
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	855000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1228037000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	16000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1315960000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-87052000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	258782000	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	282535000	USD
CY2012Q3	us-gaap	Assets Assets	383943000	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	27090000	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	173288000	USD
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85543000	shares
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	97854000	shares
CY2011Q3	us-gaap	Operating Expenses OperatingExpenses	35633000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5459000	USD
CY2011Q3	us-gaap	Revenues Revenues	6431000	USD
	us-gaap	Revenues Revenues	19150000	USD
	us-gaap	Operating Expenses OperatingExpenses	93312000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-33350000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	16981000	USD
CY2011Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7796000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22213000	USD
CY2011Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	81000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	344000	USD
CY2011Q3	us-gaap	Interest Expense InterestExpense	1505000	USD
	us-gaap	Interest Expense InterestExpense	4519000	USD
CY2011Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-30626000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-78337000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	4503000	USD
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95027000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89271000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82490000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81777000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95027000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98381000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82490000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81777000	shares
CY2012Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1430000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	4291000	USD
CY2011Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2380000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	7294000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34692000	USD
CY2012Q3	us-gaap	Revenues Revenues	1430000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12782000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34692000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	17285000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	225000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	100000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	24000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34467000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12882000	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30643000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-78313000	USD
CY2011Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27837000	USD
	us-gaap	Operating Expenses OperatingExpenses	112979000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	34780000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	8000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18706000	USD
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	16000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-113000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1983000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4567000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1446000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-679000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-2336000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14025000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-62982000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-103261000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2723000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	231284000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	8750000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	164401000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-60000	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	140000	USD
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	630000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-60366000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	166000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22917000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	22751000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-100597000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	229147000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-58429000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	67457000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163333000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112235000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44778000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Use of Management’s Estimates</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr></table>
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2563000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2461000	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2461000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2442000	shares
CY2011Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-30626000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-78337000	USD
CY2012Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	97590000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	91834000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	84951000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	84238000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2563000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	6668000	shares
CY2012Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11766000	shares
CY2011Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13412000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12873000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2915000	shares
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	235734000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	36000	USD
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	19000	USD
CY2012Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	358875000	USD
CY2012Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	124000	USD
CY2012Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	8000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	235751000	USD
CY2012Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	358991000	USD
	thrx	Marketable Securities Average Contractual Maturity Period MarketableSecuritiesAverageContractualMaturityPeriod	P9M
CY2012Q3	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	11100000	USD
CY2011Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	11400000	USD
CY2011Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	5000000	USD
CY2012Q3	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	5000000	USD
CY2012Q3	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	172500000	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	383943000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18706000	USD
CY2012Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	88962000	USD
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	161209000	USD
CY2012Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	71000	USD
CY2012Q3	us-gaap	Due From Employees Current DueFromEmployeesCurrent	100000	USD
CY2012Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3772000	USD
CY2012Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	833000	USD
CY2012Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	5275000	USD
CY2012Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5790000	USD
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	979000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9579000	USD
CY2012Q3	us-gaap	Due From Employees Noncurrent DueFromEmployeesNoncurrent	140000	USD
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1894000	USD
CY2012Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4757000	USD
CY2012Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7714000	USD
CY2012Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6761000	USD
CY2012Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1078000	USD
CY2012Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1835000	USD
CY2012Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4945000	USD
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1475371000	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	116000	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1303178000	USD
	us-gaap	Revenues Revenues	129960000	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27026000	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7754000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89778000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23201000	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	158000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	1500000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	304000	USD
	us-gaap	Interest Expense InterestExpense	4503000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5462000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18044000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-152000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	247000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-452000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3902000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	546000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-129979000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2329000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	276425000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	181495000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	38670000	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	140000	USD
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	240000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	69000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	229216000	USD
CY2011Q4	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	189600000	USD
CY2012Q3	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	206400000	USD
CY2012Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	5148000	USD

Files In Submission

Name	View Source	Status
0001104659-12-072730-index-headers.html	Edgar Link	pending
0001104659-12-072730-index.html	Edgar Link	pending
0001104659-12-072730.txt	Edgar Link	pending
0001104659-12-072730-xbrl.zip	Edgar Link	pending
a12-18972_110q.htm	Edgar Link	pending
a12-18972_1ex31d1.htm	Edgar Link	pending
a12-18972_1ex31d2.htm	Edgar Link	pending
a12-18972_1ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thrx-20120930.xml	Edgar Link	completed
thrx-20120930.xsd	Edgar Link	pending
thrx-20120930_cal.xml	Edgar Link	unprocessable
thrx-20120930_def.xml	Edgar Link	unprocessable
thrx-20120930_lab.xml	Edgar Link	unprocessable
thrx-20120930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INVA
Innoviva, Inc. Stock $inva

2012 Q4 Form 10-Q Financial Statement

#000110465912072730 Filed on October 31, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVA Innoviva, Inc. Stock $inva

2012 Q4 Form 10-Q Financial Statement

#000110465912072730 Filed on October 31, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVA
Innoviva, Inc. Stock $inva